Development of the Health Technology Assessment in the world
PDF (Português (Brasil))

Keywords

Health Technologies Assessment
Health Planning
Universal Coverage in Health

How to Cite

Trindade, E. (2013). Development of the Health Technology Assessment in the world. Boletim Do Instituto De Saúde - BIS, 14(2), 135–142. Retrieved from https://periodicos.saude.sp.gov.br/bis/article/view/34126

Abstract

The health technologies assessment (HTA) aims to systematically qualify and quantify, or develop the scientific knowledge about technology(s) relevant to healthcare program(s), to make more objective decisions to adopt, or either increase rational use or disinvestment, based on solid scientific evidence and considering the basic principles of social justice and fiscal responsibility. The influence of international HTA programs brought some relevant lessons, for example: (a) the parallel between the installed capacity and the context of experience, which can provide ideas/knowledge to develop innovations and industries, (b) the influence of the change in pattern of coverage decisions, merit and cost-effectiveness or accountability, even in health systems with private market model, ahead to the escalating costs in the health sector, (c) the systematic monitoring of care processes incorporated to discriminate improvement opportunities or parameterize potential benefits of new technologies and comparisons, and (d) the capillary work within networks potentiate capacity, number of authors and specialties, awareness, a sense of belonging and adherence to decisions, resulting in actions for the health sector with higher quality. With the best available solid foundation when making the decision, in addition to civil and legal defense of those involved in the decision, the HTA is the best response to the challenge of greater solidarity and the principles of equity and access.

PDF (Português (Brasil))

References

1. Albuquerque EM, Cassiolato JE. As especificidades do sistema de inovação do setor saúde: uma resenha da literatura como introdução a uma discussão sobre o caso brasileiro. Belo Horizonte: Federação de Sociedades de Biologia Experimental (FESBE); 2000. (Estudos FESBE, 1) [ Links ]
2. Banta D, Oortwijn W, editors. Special section: Health Technology Assessment in the European Union. Int J Technol Assess Health Care. 2000;16(2):299-630. [ Links ]
3. Chantler C, Maynard A. Should trusts be allowed to fail? If failure is inevitable, the process should be planned and managed. Brit Med J. 1997;314:1566. [ Links ]
4. Costa NR. Inovações organizacionais e de financiamento: experiências a partir do cenário internacional. In: Negri B, Di Giovanni G, organizadores. Brasil: radiografia da saúde. Campinas: Núcleo de Estudos de Políticas Públicas; 2001. p.291-305. [ Links ]
5. Department of Health and Human Services. Health, United States 2001. Hyattsville, MD: National Center for Health Statistics; 2001. p.333-4. [ Links ]
6. Dunning M, McQuay H, Milne R. Getting a GRiP. Health Serv J. 1994;104(5400):24-6. [ Links ]
7. Evans RG. Strained mercy: the economics of Canadian health care. Toronto: Butterworths; 1984. 390 p. [ Links ]
8. Gaensler E, Jonsson E, Neuhauser D. Controlling medical technology in Sweden. In: Banta HD, Kemp KB, editors. The management of health care technology in nine countries. New York: Springer; 1982. p.167-92. [ Links ]
9. Hanson EJ. The public finance aspects of health services in Canada. Ottawa: Queen’s Printer; 1963. 206 p. [ Links ]
10. Klein R. The new politics of the NHS. London: Longman; 1996. [ Links ]
11. Klein R. Why Britain is reorganizing its national health service- yet again. Health Affairs [periódico na internet ].1998 [acesso em 19 fev 2013];17(4):111-25. Disponível em http://content.healthaffairs.org/content/17/4/111.full.pdf+html [ Links ]
12. Lymberis A, Olsson S. Intelligent biomedical clothing for personal health and disease management: state state of the art and future vision. Telemed J E Health [periódico na internet ].2003 [Acesso em 19 fev 2013];9(4):379-86. Disponível em: http://www.orcatech.org/papers/home_monitoring/03_Lymberis_biomedical_clothing.pdf [ Links ]
13. NBIC Convergence 2003: Converging Technologies for Improving Human Performance; 2003 February 5-7; Los Angeles, California, USA. Proceedings. Ann N Y Acad Sci. 2004;1013:1-259. [ Links ]
14. Office of Health Economics. Compendium of Health Statistics. London: Office of Health Economics, 1995. [ Links ]
15. Organisation for Economic Co-Operation and Development. Biotechnology and Medical Innovation: Socio-economic Assessment of the Technology, the Potential and the Products. OECD, 1997. 265p. [ Links ]
16. Oxley H, MacFarland M. Health care reform controlling spending and increasing efficiency. Paris: Organisation for Economic Co-Operation and Development; 1994. [ Links ]
17. Roco MC. Science and technology integration for increased human potential and societal outcomes. Ann N Y Acad Sci. 2004;1013:1-16. [ Links
18 Rosenberg N. Perspectives on technology. Cambridge: Cambridge University; 1976. [ Links ]
19. Simanis JG, Coleman JR. Health Care Expenditures in Nine Industrialized Countries, 1960-1976. Social Security Bulletin. 1980;43(3):10. [ Links ]
20. SPRI. Magnetic resonance imaging: Issues of costs and benefits. Stockholm: SPRI, 1984. [ Links ]
21. Thomas LG. Implicit industrial policy: the triumph of Britain over France in global pharmaceuticals. Industrial and Corporate Change. 1994;3(2). [ Links ]
22. US Congress, House of Representatives, Committee on Science and Astronautics. Technology Assessment. Statement of Emilio Q. Daddario, chair, Subcommittee on Science, Research and Development. Washington: 90th Congress, 1st session; 1967. p. 9-13.
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2013 Evelinda Trindade

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...